Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.09.20.461028

A Methodology for Vertical Translation Between Molecular and Organismal Level in Biological Feedback Loops

Abstract

Feedback loops are among the primary network motifs in living organisms, ensuring survival via homeostatic control of key metabolites and physical properties. However, from a scientific perspective, their characterization is unsatisfactory since the usual modelling methodology is incompatible with the physiological and biochemical basis of metabolic networks. Therefore, any "vertical translation", i.e. the study of the correspondence between molecular and organismal levels of causality, is difficult and in most cases impossible. As a viable solution, we demonstrate an alternative modelling platform for biological feedback loops that is based on key biochemical principles, including mass action law, enzyme kinetics, binding of mediators to transporters and receptors, and basic pharmacological properties. Subsequently, we show how this framework can be used for translating from molecular to systems-level behaviour. Basic elements of the proposed modelling platform include Michaelis-Menten kinetics defining nonlinear dependence of the output y(t) on an input signal x(t) with the Hill-Langmuir equation y(t) = G * x(t)n / (D + x(t)n), non-competitive inhibition for linking stimulatory and inhibitory inputs with y(t) = G + x1(t) / ((D + x1(t) * (1 + x2(t) / KI)) and processing structures for distribution and elimination. Depending on the structure of the feedback loop, its equifinal (steady-state) behaviour can be solved in form of polynomials, with a quadratic equation for the simplest case with one feedback loop and a Hill exponent of 1, and higher-grade polynomials for additional feedback loops and/or integer Hill exponents > 1. As a companion to the analytical solution, a flexible class library (CyberUnits) facilitates computer simulations for studying the transitional behaviour of the feedback loop. Unlike other modelling strategies in biocybernetics and systems biology, this platform allows for straightforward translation from the statistical properties of single molecules on a "microscopic" level to the behaviour of the whole feedback loop on an organismal "macroscopic" level. An example is the Michaelis constant D, which is equivalent to (k-1 + k2) / k1, where k1, k-1 and k2 denote the rate constants for the association and dissociation of the enzyme-substrate or receptor-hormone complex, respectively. From the perspective of a single molecule the rate constants represent the probability (per unit time) that the corresponding reaction will happen in the subsequent time interval. Therefore 1/k represents the mean lifetime of the complex. Very similar considerations apply to the other described constants of the feedback loop. In summary, this modelling technique renders the translation from a molecular level to a systems perspective possible. In addition to providing new insights into the physiology of biological feedback loops, it may be a valuable tool for multiple disciplines of biomedical research, including drug design, molecular genetics and investigations on the effects of endocrine disruptors.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dietrich, J. W.. 2021-09-23. A Methodology for Vertical Translation Between Molecular and Organismal Level in Biological Feedback Loops. https://doi.org/10.1101/2021.09.20.461028

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗